A new review published in Antioxidants journal highlights why Alpha-Lipoic Acid (ALA) is one of the most powerful and versatile antioxidants known today.
Longzen Makes a Remarkable Debut at CPHI China 2025
Shanghai, June 26, 2025 — The 23rd CPHI China 2025, one of the world’s premier pharmaceutical trade shows, successfully concluded at the Shanghai New International Expo Centre.
Longzen Receives First GMP Compliance Notification for Active Pharmaceutical Ingredient Gadobutrol
We are proud to announce that Longzen has officially received its first Drug GMP Compliance Notification.
Unlocking the Power of Alpha Lipoic Acid: A More Stable Antioxidant with Sodium
This issue can be resolved by converting ALA into a more stable form, such as Alpha Lipoic Acid Sodium, through salt formation with sodium or other stabilizing agents.
White Paper | What’s important when choosing your R-lipoic acid sodium (R-ALA Na)?
Longzen’s R-ALA Na answers 3 key criteria
© Copyright 2023 Shandong Longzen Pharmaceutical Co., Ltd